Sign In
to Vote &
Create Storyboards.
 
Wall Street is expecting higher profit for PDL BioPharma when the company reports its fourth quarter results on Monday, March 3, 2014. The consensus estimate is calling for profit of 41 cents a share, a rise from 34 cents per share a year ago.For the fiscal year, analysts are expecting
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard